Clinical trial
A Randomized, Multicenter, Open-Label, Parallel-Group Clinical Study Comparing the Safety and Efficacy of MYL-1601D With NovoLog® in Type 1 Diabetes Mellitus Patients
NCT03760068 is registered in ClinicalTrials.gov with Mylan Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized, Multicenter, Open-Label, Parallel-Group Clinical Study Comparing the Safety and Efficacy of MYL-1601D With NovoLog® in Type 1 Diabetes Mellitus Patients
- Lead sponsor
- Mylan Inc.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- November 7, 2018
- Completion date
- January 17, 2020
- Enrollment
- 478 (actual)
- Sites
- 158
Conditions
As the registry lists them; a condition with its own page is linked.